Medical Dosimetry
Volume 36, Issue 3 , Pages 264-271 , Autumn 2011

Treatment and Dosimetric Advantages Between VMAT, IMRT, and Helical TomoTherapy in Prostate Cancer

  • Chiao-Ling Tsai, M.D.

      Affiliations

    • Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Jian-Kuen Wu, M.S.

      Affiliations

    • Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Hsiao-Ling Chao, M.S.

      Affiliations

    • Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Yi-Chun Tsai, M.S.

      Affiliations

    • Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Jason Chia-Hsien Cheng, M.D., M.S., Ph.D.

      Affiliations

    • Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
    • Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan
    • Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan
    • Corresponding Author InformationReprint requests to: Jason Chia-Hsien Cheng, M.D., M.S., Ph.D., Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, No. 7 Chung-Shan South Road, Taipei 100, Taiwan

Received 21 February 2010 ,Accepted 10 May 2010.

References 

  1. Dearnaley DP, Sydes MR, Graham JD, et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet. Oncol. 2007;8:475–487
  2. Peeters ST, Heemsbergen WD, Koper PC, et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J. Clin. Oncol. 2006;24:1990–1996
  3. Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA. 2005;294:1233–1239
  4. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 2002;53:1097–1105
  5. Zelefsky MJ, Fuks Z, Happersett L, et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother. Oncol. 2000;55:241–249
  6. Zelefsky MJ, Fuks Z, Hunt M, et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int. J. Radiat. Oncol. Biol. Phys. 2002;53:1111–1116
  7. Cahlon O, Hunt M, Zelefsky MJ. Intensity-modulated radiation therapy: supportive data for prostate cancer. Semin. Radiat. Oncol. 2008;18:48–57
  8. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med. Phys. 2008;35:310–317
  9. Pardo-Montero J, Fenwick JD. An approach to multiobjective optimization of rotational therapy. Med. Phys. 2009;36:3292–3303
  10. Kjaer-Kristoffersen F, Ohlhues L, Medin J, et al. RapidArc volumetric modulated therapy planning for prostate cancer patients. Acta. Oncol. 2009;48:227–232
  11. Zhang P, Happersett L, Hunt M, et al. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases. IntJ. Radiat. Oncol. Biol. Phys. 2010;76:1456–1462
  12. Tsai CL, Wu JK, Wang CW, et al. Using cone-beam computed tomography to evaluate the impact of bladder filling status on target position in prostate radiotherapy. Strahlenther. Onkol. 2009;185:588–595
  13. Holmes TW, Mackie TR, Reckwerdt P. An iterative filtered backprojection inverse treatment planning algorithm for tomotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1995;32:1215–1225
  14. Wilcox EE, Daskalov GM. Evaluation of GAFCHROMIC EBT film for Cyberknife dosimetry. Med. Phys. 2007;34:1967–1974
  15. Low DA, Gerber RL, Mutic S, et al. Phantoms for IMRT dose distribution measurement and treatment verification. Int. J. Radiat. Oncol. Biol. Phys. 1998;40:1231–1235
  16. Schreibmann E, Dhabaan A, Elder E, et al. Patient-specific quality assurance method for VMAT treatment delivery. Med. Phys. 2009;36:4530–4535
  17. IMRT CWG. Intensity-modulated radiotherapy: current status and issues of interest. Int. J. Radiat. Oncol. Biol. Phys. 2001;51:880–914
  18. Han C, Liu A, Schultheiss TE, et al. Dosimetric comparisons of helical tomotherapy treatment plans and step-and-shoot intensity-modulated radiosurgery treatment plans in intracranial stereotactic radiosurgery. Int. J. Radiat. Oncol. Biol. Phys. 2006;65:608–616
  19. Khan HA. CalcNTCP: a simple tool for computation of normal tissue complication probability (NTCP) associated with cancer radiotherapy. Int. J. Radiat. Biol. 2007;83:717–720
  20. Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat. Res. Suppl. 1985;8:S13–S19
  21. Burman C, Kutcher GJ, Emami B, et al. Fitting of normal tissue tolerance data to an analytic function. Int. J. Radiat. Oncol. Biol. Phys. 1991;21:123–135
  22. Wu Q, Mohan R, Niemierko A, et al. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int. J. Radiat. Oncol. Biol. Phys. 2002;52:224–235
  23. Palma D, Vollans E, James K, et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2008;72:996–1001
  24. Ulrich S, Sterzing F, Nill S, et al. Comparison of arc-modulated cone beam therapy and helical tomotherapy for three different types of cancer. Med. Phys. 2009;36:4702–4710
  25. Enmark M, Korreman S, Nystrom H. IGRT of prostate cancer; is the margin reduction gained from daily IG time-dependent?. Acta. Oncol. 2006;45:907–914
  26. Followill D, Geis P, Boyer A. Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy. Int. J. Radiat. Oncol. Biol. Phys. 1997;38:667–672
  27. Sterzing F, Schubert K, Sroka-Perez G, et al. Helical tomotherapy (Experiences of the first 150 patients in Heidelberg). Strahlenther. Onkol. 2008;184:8–14
  28. Pollack A, Price RA, Dong L, et al. Intact prostate cancer: overview. In:  Mundt AJ,  Roeske JC editor. Intensity Modulated Radiation Therapy: A Clinical Perspective. Hamilton, ON, Canada: BC Decker; 2005;p. 459–463
  29. Teh BS, Dong L, McGary JE, et al. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer. Med. Dosim. 2005;30:25–30

PII: S0958-3947(10)00067-1

doi: 10.1016/j.meddos.2010.05.001

Medical Dosimetry
Volume 36, Issue 3 , Pages 264-271 , Autumn 2011

Article Tools

* Image Usage & Resolution